Sysmex Inostics
Biotechnology ResearchView the employees at
Sysmex Inostics-
Jen Swindell (Preston) Mom | Equestrian | Baltimore Sports Fan | Customer Oriented Clinical Project Manager
-
White Hall, Maryland, United States
-
Rising Star
-
Hamburg, Hamburg, Germany
-
Rising Star
Karin Ballas Head Production bei Sysmex Inostics-
Rising Star
Jem Emerick Recent graduate constantly seeking opportunities to learn and grow-
Catonsville, Maryland, United States
-
Rising Star
Elizabeth Wieber Clinical Laboratory Technologist at Sysmex Inostics-
Sykesville, Maryland, United States
-
Rising Star
Overview
Leaders of the Global Liquid Biopsy Revolution As pioneers in blood-based cell-free tumor DNA (ctDNA) mutation detection, Sysmex Inostics has provided custom assays and CLIA-certified lab services to leading BioPharma companies over the last 10 years with the overall goal: to develop therapeutics that extend lives and provide diagnostics to monitor response to therapy, identify targetable resistance alterations, and detect minimal residual disease (MRD). SafeSEQ NGS technology can detect clinically relevant mutations in circulating tumor DNA (ctDNA) with robust detection as low as 0.03% mutant allele frequency (MAF), thus ensuring reliable molecular information for real-time therapy selection as well as monitoring of tumor response from across a broader range of genomic regions.
-